Prescription drugs prices establishment subject to the Medicare Drug Price Negotiation Program
Introduction and first reading; Referred to
Summary
The bill creates a "maximum fair price" for certain prescription drugs based on the federal Medicare negotiation program. It bars manufacturers from charging more than that price, requires health plans and pharmacy benefit managers to reimburse pharmacies at least the higher of the maximum fair price or the national average acquisition cost, and forces reporting of drug payment details to the state Prescription Drug Affordability Board. It also penalizes manufacturers who pull a drug from the market to avoid the price limits.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get an email when SF 5302 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SF 5302 freeOr ask your AI assistant about SF 5302 directly:
Add to Claude, ChatGPT or Cursor